OrigAMI-4

The purpose of this study is to determine safety and preliminary efficacy of amivantamab monotherapy, amivantamab in addition to pembrolizumab, amivantamab in addition to paclitaxel and amivantamab in addition to pembrolizumab and carboplatin in participants with recurrent/metastatic head and neck cancer.

• Studientyp: prospektive Studie
• Tumorart: Kopf-Hals-Tumoren
• Entität: Keine Unterkategorie
• Standort:
  • Klinikum Stuttgart
  • E-Mail: scc-studienzentrale@klinikum-stuttgart.de
  • Tel.: 0711 278-30410
  • Website
• Rekrutierungsstatus: rekrutierend
• Alter: 18+
• Studienphase: Phase1b/2
• Weitere Informationen